Enrico Martin

41 Treatment and survival differences across tumor sites 18. Baehring JM, Betensky RA, Batchelor TT. Malignant peripheral nerve sheath tumor: the clinical spectrum and outcome of treatment. Neurology . 2003;61(5):696-698. 19. Hruban RH, Shiu MH, Senie RT, Woodruff JM. Malignant peripheral nerve sheath tumors of the buttock and lower extremity. A study of 43 cases. Cancer . 1990;66(6):1253-1265. 20. Kourea HP, Bilsky MH, Leung DH, Lewis JJ, Woodruff JM. Subdiaphragmatic and intrathoracic paraspinal malignant peripheral nerve sheath tumors: a clinicopathologic study of 25 patients and 26 tumors. Cancer . 1998;82(11):2191-2203. 21. Wanebo JE, Malik JM, VandenBerg SR, Wanebo HJ, Driesen N, Persing JA. Malignant peripheral nerve sheath tumors. A clinicopathologic study of 28 cases. Cancer . 1993;71(4):1247-1253. 22. Wong WW, Hirose T, Scheithauer BW, Schild SE, Gunderson LL. Malignant peripheral nerve sheath tumor: analysis of treatment outcome. Int J Radiat Oncol Biol Phys . 1998;42(2):351-360. 23. Kahn J, Gillespie A, Tsokos M, et al. Radiation therapy in management of sporadic and neurofibromatosis type 1-associated malignant peripheral nerve sheath tumors. Front Oncol . 2014;4:324. doi:10.3389/fonc.2014.00324 24. Widemann BC, Reinke DK, Helman LJ, et al. SARC006: Phase II trial of chemotherapy in sporadic and neurofibromatosis type 1 (NF1)-associated high-grade malignant peripheral nerve sheath tumors (MPNSTs). J Clin Oncol . 2013;31(15_suppl):10522. doi:10.1200/jco.2013.31.15_suppl.10522 25. Gronchi A, Ferrari S, Quagliuolo V, et al. Histotype-tailored neoadjuvant chemotherapy versus s tandard chemotherapy in patients with high-risk soft-tissue sarcomas (ISG-STS 1001): an international, open-label, randomised, controlled, phase 3, multicentre trial. Lancet Oncol . 2017;18(6):812-822. doi:10.1016/S1470-2045(17)30334-0 26. Sordillo PP, Helson L, Hajdu SI, et al. Malignant schwannoma--clinical characteristics, survival, and response to therapy. Cancer . 1981;47(10):2503-2509. 27. Gousias K, Bostrom J, Kovacs A, Niehusmann P, Wagner I, Kristof R. Factors of influence upon overall survival in the treatment of intracranial MPNSTs. Review of the literature and report of a case. Radiat Oncol . 2010;5:114. doi:10.1186/1748- 717X-5-114 28. Scheithauer BW, Erdogan S, Rodriguez FJ, et al. Malignant peripheral nerve sheath tumors of cranial nerves and intracranial contents: a clinicopathologic study of 17 cases. Am J Surg Pathol . 2009;33(3):325- 338. doi:10.1097/PAS.0b013e31818d6470 29. L’heureux-Lebeau B, Saliba I. Updates on the diagnosis and treatment of intracranial nerve malignant peripheral nerve sheath tumors. Onco Targets Ther . 2013;6:459-470. doi:10.2147/OTT.S41397 30. Chen L, Mao Y, Chen H, Zhou L-F. Diagnosis and management of intracranial malignant peripheral nerve sheath tumors. Neurosurgery . 2008;62(4):825- 832; discussion 832. doi:10.1227/01. neu.0000318167.97966.f3 31. Ren X, Wang J, Hu M, Jiang H, Yang J, Jiang Z. Clinical, radiological, and pathological features of 26 intracranial and intraspinal malignant peripheral nerve sheath tumors. J Neurosurg . 2013;119(3):695-708. doi:10.3171/2013.5.JNS122119 32. Carli M, Ferrari A, Mattke A, et al. Pediatric malignant peripheral nerve sheath tumor: the Italian and German soft tissue sarcoma cooperative group. J Clin Oncol . 2005;23(33):8422-8430. doi:10.1200/ JCO.2005.01.4886 33. Vege DS, Chinoy RF, Ganesh B, Parikh DM. Malignant peripheral nerve sheath tumors of the head and neck: a clinicopathological study. J Surg Oncol . 1994;55(2):100-103. 34. Minovi A, Basten O, Hunter B, Draf W, Bockmuhl U. Malignant peripheral nerve sheath tumors of the head and neck: management of 10 cases and literature review. Head Neck . 2007;29(5):439-445. doi:10.1002/hed.20537 2